Emmaus Life Sciences Responds to Announcement Made by AFH

Emmaus Life Sciences Inc., a company that develops innovative and cost-effective therapies and treatments for rare diseases, issued a statement in response to the announcement made by AFH Holdings & Advisory, LLC issued on January 24^, 2013.

As quoted in a press release:

AFH Holding & Advisory and its counsel have misrepresented the nature and effect of a recent ruling by the Los Angeles Superior Court. Far from “preventing [Emmaus] from pursuing a lawsuit it had filed” against AFH Holding & Advisory, the court’s decision merely stayed the proceedings in California and held that the claims are contractually required to be brought in Delaware, where Emmaus is currently engaged in litigation against AFH Holding & Advisory and its principal Amir Heshmatpour.

Click here to read the full press release.